Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Mistakes disrupt budgets and derail goals. Explore how small oversights impact finances and how to recalibrate for stable, predictable spending.
27,871 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
What looked like a cautious second quarter instead became a showcase of corporate resilience. This piece breaks down ...
In a volatile market, a straightforward approach is gaining traction: carve out an income sleeve that pays a steady $...
As June approaches, Netflix stock may be on the radar for investors seeking a rebound. This article highlights three ...
Forecasting Tesla is never dull. This article lays out base, bull, and bear scenarios for the next five years, with a...
Tech investors shifted away from growth plays as inflation data fed rate worries. This article explains why marvell t...
A look at the CEO's statements and what they mean for marvell stock investors amazing. Learn actionable steps, risk f...
Investors are buzzing after Simulations Plus announced a cash buyout at $18.50 per share. This deep-dive explains why...
Investors often chase eye-popping targets, but can Nvidia stock truly double in 12 months? This article breaks down t...
delek holdings rallied today captured market attention as a mid-cap refiner with jet-fuel exposure and a strategic st...
Could Zcash flip Bitcoin? This article breaks down how Zcash’s privacy features, regulatory dynamics, and market tren...
As bars face shifting economics, bartenders can take control of their retirement with self-funded accounts. This piec...